A three-dimensional valve-on-chip microphysiological system implicates cell cycle progression, cholesterol metabolism

Ishita Tandon1, Alan E Woessner2, Laίs A Ferreira1

  • 1Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.

Acta Biomaterialia
|July 31, 2024
PubMed

Insights

Researchers developed a 3D valve-on-chip model using a bilayer hydrogel to study calcific aortic valve disease (CAVD). This model revealed early disease mechanisms by mimicking the aortic valve

Area of Science:

  • Biomaterials Science
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • Calcific aortic valve disease (CAVD) is a common valvulopathy with a 50% increased risk of fatal cardiovascular events.
  • Current treatment relies on valve replacement due to underdeveloped early diagnostic and therapeutic strategies.
  • Effective in vitro models are crucial for understanding early CAVD mechanisms and developing new interventions.

Purpose of the Study:

  • To develop a physiologically relevant 3D valve-on-chip (VOC) system to model CAVD.
  • To investigate early CAVD mechanisms using a biomimetic in vitro system.
  • To provide a platform for assessing potential diagnostic and therapeutic strategies.

Main Methods:

  • Fabrication of a multilayered, bilayered hydrogel system mimicking aortic valve extracellular matrix (ECM) composition.
  • Incorporation of porcine aortic valve interstitial cells (VICs) and endothelial cells (VECs) for co-culture.
  • Application of dynamic mechanical stimuli and assessment using multiphoton imaging and proteomic analysis.

Main Results:

  • The collagen-based bilayered hydrogel successfully maintained VIC phenotype.
  • Proteomic analysis revealed significant alterations in proteins related to cell cycle, cholesterol biosynthesis, and protein homeostasis in diseased VOCs.
  • These alterations correlated with changes in cell metabolism, suggesting an early, adaptive disease initiation stage.

Conclusions:

  • The developed VOC system effectively mimics healthy and diseased aortic valve compositions.
  • Diseased VOCs provide key insights into the initiation process of CAVD.
  • The findings support the VOC as a valuable tool for studying early-stage CAVD and developing novel therapeutic approaches.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...